Home LiteratureArticle Details
PMID: 17548521 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.

The Journal of experimental medicine ·Vol. 204 ·No. 6 ·2007-06-11 ·Pages 1335-47

Sather BD, Treuting P, Perdue N, Miazgowicz M, Fontenot JD, Rudensky AY, Campbell DJ

Abstract

CD4(+)Foxp3(+) regulatory T cells (T reg) are essential for maintaining self-tolerance, but their functional mechanisms and sites of action in vivo are poorly defined. We examined the homing receptor expression and tissue distribution of T reg cells in the steady state and determined whether altering their distribution by removal of a single chemokine receptor impairs their ability to maintain tissue-specific peripheral tolerance. We found that T reg cells are distributed throughout all nonlymphoid tissues tested, and are particularly prevalent in the skin, where they express a unique CCR4(+)CD103(hi) phenotype. T reg cell expression of CCR4 and CD103 is induced by antigen-driven activation within subcutaneous lymph nodes, and accumulation of T reg cells in the skin and lung airways is impaired in the absence of CCR4 expression. Mice with a complete loss of CCR4 in the T reg cell compartment develop lymphocytic infiltration and severe inflammatory disease in the skin and lungs, accompanied by peripheral lymphadenopathy and increased differentiation of skin-tropic CD4(+)Foxp3(+) T cells. Thus, selectively altering T reg cell distribution in vivo leads to the development of tissue-specific inflammatory disease.

MeSH Terms
Adoptive Transfer Animals Antigens, CD/metabolism Flow Cytometry Forkhead Transcription Factors/immunology,metabolism Inflammation/etiology,immunology,pathology Integrin alpha Chains/metabolism Mice Mice, Inbred BALB C Mice, Inbred C57BL Receptors, CCR4/metabolism Self Tolerance/immunology Skin/immunology,metabolism T-Lymphocytes, Regulatory/immunology,metabolism
Chemicals
Antigens, CD Ccr4 protein, mouse Forkhead Transcription Factors Foxp3 protein, mouse Integrin alpha Chains Receptors, CCR4 alpha E integrins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Sather Blythe D
Benaroya Research Institute, Seattle, WA 98101, USA.
Treuting Piper
Perdue Nikole
Miazgowicz Mike
Fontenot Jason D
Rudensky Alexander Y
Campbell Daniel J
References (61)
61 references, click to expand
  1. Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets.
    Curr Top Microbiol Immunol. 2005;293:89-114 PMID: 15981477
  2. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.
    J Exp Med. 2003 Jul 21;198(2):249-58 PMID: 12874258
  3. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
    Blood. 2005 Nov 1;106(9):3300-7 PMID: 16002422
  4. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo.
    Blood. 2005 Nov 1;106(9):3097-104 PMID: 16014565
  5. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.
    J Exp Med. 2005 Nov 21;202(10):1387-97 PMID: 16301745
  6. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.
    Nat Immunol. 2006 Jan;7(1):83-92 PMID: 16311599
  7. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo.
    J Exp Med. 2006 Mar 20;203(3):505-11 PMID: 16533880
  8. CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses.
    J Immunol. 2006 Sep 15;177(6):4149-58 PMID: 16951380
  9. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors.
    J Immunol. 2006 Oct 1;177(7):4488-94 PMID: 16982885
  10. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.
    J Immunol. 2006 Nov 1;177(9):5852-60 PMID: 17056509
  11. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.
    J Exp Med. 2006 Oct 30;203(11):2451-60 PMID: 17015634
  12. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
    Nat Immunol. 2007 Feb;8(2):191-7 PMID: 17136045
  13. Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions.
    J Immunol. 2007 Mar 15;178(6):3358-62 PMID: 17339428
  14. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
    J Exp Med. 2001 Sep 17;194(6):847-53 PMID: 11560999
  15. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.
    J Exp Med. 2001 Nov 19;194(10):1541-7 PMID: 11714760
  16. Control of intestinal inflammation by regulatory T cells.
    Immunol Rev. 2001 Aug;182:190-200 PMID: 11722634
  17. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.
    J Exp Med. 2002 Jan 7;195(1):135-41 PMID: 11781372
  18. Mouse langerhans cells differentially express an activated T cell-attracting CC chemokine.
    J Invest Dermatol. 1999 Dec;113(6):991-8 PMID: 10594742
  19. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
    Immunity. 2000 Apr;12(4):431-40 PMID: 10795741
  20. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock.
    J Exp Med. 2000 May 15;191(10):1755-64 PMID: 10811868
  21. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells.
    J Immunol. 2000 Aug 15;165(4):2205-13 PMID: 10925308
  22. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines.
    Curr Opin Cell Biol. 2000 Oct;12(5):563-8 PMID: 10978890
  23. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects.
    J Immunol. 2001 Feb 15;166(4):2842-8 PMID: 11160352
  24. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue.
    Am J Pathol. 2001 Apr;158(4):1263-70 PMID: 11290544
  25. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.
    J Exp Med. 2003 Sep 15;198(6):963-9 PMID: 12963696
  26. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.
    J Exp Med. 2003 Sep 15;198(6):889-901 PMID: 12975455
  27. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.
    J Clin Invest. 2003 Dec;112(11):1688-96 PMID: 14660744
  28. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets.
    J Immunol. 2004 Jan 15;172(2):857-63 PMID: 14707056
  29. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.
    J Exp Med. 2004 Feb 2;199(3):303-13 PMID: 14757740
  30. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.
    Annu Rev Immunol. 2004;22:531-62 PMID: 15032588
  31. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors.
    Immunity. 2004 Aug;21(2):267-77 PMID: 15308106
  32. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion.
    J Immunol. 2004 Sep 1;173(5):2942-51 PMID: 15322152
  33. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function.
    J Exp Med. 1989 Nov 1;170(5):1569-81 PMID: 2572671
  34. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.
    Am J Pathol. 1991 Jun;138(6):1379-87 PMID: 2053595
  35. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.
    Cell. 1993 Oct 22;75(2):253-61 PMID: 8402910
  36. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.
    Science. 1995 Jun 9;268(5216):1472-6 PMID: 7770771
  37. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
    J Exp Med. 1996 Aug 1;184(2):387-96 PMID: 8760792
  38. Age-dependent intestinal lymphoproliferative disorder due to stem cell factor receptor deficiency: parameters in small and large intestine.
    J Immunol. 1997 Feb 1;158(3):1417-27 PMID: 9013987
  39. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells.
    J Exp Med. 1998 Aug 3;188(3):451-63 PMID: 9687523
  40. Characterization of E-cadherin-containing junctions involving skin-derived dendritic cells.
    J Invest Dermatol. 1999 Jan;112(1):102-8 PMID: 9886272
  41. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells.
    Science. 1999 Apr 30;284(5415):819-22 PMID: 10221917
  42. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.
    Nature. 1999 Aug 19;400(6746):776-80 PMID: 10466728
  43. The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells.
    Eur J Immunol. 1999 Sep;29(9):2684-94 PMID: 10508243
  44. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells.
    J Invest Dermatol. 2005 Feb;124(2):343-50 PMID: 15675953
  45. Regulatory T cell lineage specification by the forkhead transcription factor foxp3.
    Immunity. 2005 Mar;22(3):329-41 PMID: 15780990
  46. Mechanisms of suppression by suppressor T cells.
    Nat Immunol. 2005 Apr;6(4):338-44 PMID: 15785759
  47. A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations.
    J Exp Med. 2005 Apr 4;201(7):1045-51 PMID: 15795234
  48. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.
    J Exp Med. 2005 Apr 4;201(7):1037-44 PMID: 15809349
  49. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection.
    J Immunol. 2005 May 1;174(9):5444-55 PMID: 15845457
  50. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis.
    J Immunol. 2005 Jun 15;174(12):7487-91 PMID: 15944246
  51. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.
    Am J Pathol. 2002 Jan;160(1):347-55 PMID: 11786428
  52. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    J Immunol. 2002 Feb 1;168(3):1080-6 PMID: 11801641
  53. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice.
    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8213-8 PMID: 12034883
  54. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.
    J Med Genet. 2002 Aug;39(8):537-45 PMID: 12161590
  55. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
    J Immunol. 2002 Sep 1;169(5):2461-5 PMID: 12193715
  56. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells.
    Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13031-6 PMID: 12242333
  57. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
    J Immunol. 2002 Nov 1;169(9):4712-6 PMID: 12391178
  58. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.
    Nature. 2002 Dec 5;420(6915):502-7 PMID: 12466842
  59. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen.
    J Exp Med. 2003 Mar 3;197(5):585-99 PMID: 12615900
  60. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Nat Immunol. 2003 Apr;4(4):330-6 PMID: 12612578
  61. How defects in central tolerance impinge on a deficiency in regulatory T cells.
    Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14735-40 PMID: 16203996
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2007-06-11
Epub
2007-00-04
Pages
1335-47
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118615
Subset
IM
Grants
NIDDK NIH HHS · R01 DK072295 · United States
NCI NIH HHS · T32 CA09537 · United States
NIDDK NIH HHS · DK072295 · United States
NIAID NIH HHS · AI067750 · United States
NCI NIH HHS · T32 CA009537 · United States
NIAID NIH HHS · R56 AI067750 · United States
NIAID NIH HHS · R01 AI067750 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com